Commentary

Unhealthy drinking may worsen after weight loss surgery


 

Internal medicine primarily affords us the skill to cope with disorders of chronicity that rarely disappear. For every pneumococcal pneumonia we eradicate, we have multiple patients with HIV who will be treated indefinitely. Diabetes, once a lethal disease, is now a chronic condition for most patients, and even with treatment the trajectory is usually one of progression.

Dr. Richard M. Plotzker is a retired endocrinologist with 40 years of experience treating patients in both private practice and hospital settings.

Dr. Richard M. Plotzker

One gratifying exception in my professional lifetime has been the introduction of gastric surgeries that reduce morbidity and seem to extend the life span of those who successfully undergo these procedures. The Roux-en-Y gastric bypass and sleeve gastrectomy have kept thousands of patients in better health for many years, giving them a second chance. For a subset, however, this second chance comes with a stumbling block of substance use – most notably alcohol – that exceeds their preoperative use.

Increased alcohol use after surgery

A group affiliated with the Department of Veterans Affairs (VA) recently reviewed the large central database to identify changes in alcohol consumption among patients who had undergone successful bariatric surgery. The VA regularly administers the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C), a survey validated as a reliable estimate of individual alcohol consumption. It is inserted into the VA electronic health record where it can be readily retrieved. By matching these survey results with individuals who underwent bariatric surgery at the VA and survived at least 8 years post op, the authors were able to follow trends in alcohol consumption, beginning 2 years before surgery through 8 years after.

Using the same database, the authors identified a larger number of nonoperative control patients with slightly less obesity but otherwise matched for several elements of comorbidity, such as hypertension, certain psychiatric disorders, and personal habits, including alcohol consumption.

Alcohol use was categorized as none, minor social use, and “unhealthy” use. Among those with no or minor social use preoperatively, 4% converted to unhealthy use at 3 years and about 5% at 8 years, significantly more than in the nonoperative control group. Those who had gastric bypass had somewhat more conversion than did those who had sleeve gastrectomy, though not significantly so.

Patients with an alcohol concern preoperatively took an interesting course. Consumption declined from 2 years pre op to the year of surgery, suggesting that curtailing its use may have been a surgical precondition. Postoperatively, they returned to unhealthy drinking levels. Those who underwent the sleeve gastrectomy consumed about the same amount of alcohol as did their matched nonoperative controls, but those who underwent bypass increased their baseline unhealthy use beyond that of the controls.

Because total abstinence is often the recommendation for treating alcoholism, the research group assessed how adherent the excessive drinkers were to abstinence. In anticipation of surgery, the rates of abstinence increased until the year of surgery, but by 3 years post op, consumption was often up to unhealthy levels, though no more than that of control participants with preexisting drinking problems.

Pages

Recommended Reading

Being overweight ups risk of severe COVID-19 in hospital
MDedge Cardiology
Weight-related COVID-19 severity starts in normal BMI range, especially in young
MDedge Cardiology
Exercise plus liraglutide better for maintaining weight loss than either strategy alone
MDedge Cardiology
A simple new definition for ‘metabolically healthy obesity’?
MDedge Cardiology
Possible obesity effect detected in cancer death rates
MDedge Cardiology
High teen BMI linked to stroke risk in young adulthood
MDedge Cardiology
Vegetarians have better cholesterol levels, and more, than meat eaters
MDedge Cardiology
‘Inflammasomes’ may play a role in obesity-related CRC
MDedge Cardiology
Herbal and dietary weight-loss supplements: No evidence that they work
MDedge Cardiology
Obesity hope as neuropeptide Y blocker turns white fat to brown
MDedge Cardiology